BioSpace News Archive

Policy

What’s Next for COVID-19? All Signs Point to Boosters

As COVID-19 surges to earlier pandemic levels in the U.S., federal health officials are expected to authorize a third booster shot eight months after receiving the second of the Moderna and Pfizer-BioNTech vaccines, and probably the Johnson & Johnson vaccine as well.

August 17, 2021
·
5 min read
·
Mark Terry
Drug Development

Moderna to Launch Clinical Trials for mRNA-Based HIV Vaccine

Moderna is expected to launch a human clinical trial as early as this week for an mRNA-based vaccine against HIV and indicated that it is looking for 56 people ages 18 to 50 who are HIV-negative.

August 17, 2021
·
3 min read
·
Mark Terry
Genetown

Bain Life Sciences Raises $1.9 Billion to Help Fund Promising Underdogs

The goal was to find and finance promising endeavors, including clinical trials that need a financial push, companies looking to expand globally, and firms that have experienced drops recently.

August 17, 2021
·
2 min read
·
Vanessa Doctor, RN
Augmented Reality in Healthcare Market Size to Reach $4.23 billion, Growing at a CAGR of 27.4% by 2026

Increase in application of AR in rehabilitation, diagnostic imaging, surgical simulation, and patient care management along with surge in number of AR-based startups propel the growth of the global AR in healthcare market.

August 17, 2021
·
3 min read
Business

Former Medivation Exec Charged with Insider Trading Ahead of 2016 Pfizer Acquisition

The latest biopharma insider trading scandal stems from Pfizer’s acquisition of Medivation in 2016.

August 17, 2021
·
2 min read
·
Ellen Bombela
Genetown

Diagnostic Face Mask Detects SARS-CoV-2 Quickly, with PCR-Like Accuracy

The prototype offers PCR-like precision without a power-source, and is stable at room temperature for many months.

August 17, 2021
·
4 min read
·
Gail Dutton
Drug Development

mRNA Looks Beyond COVID-19 Vaccines to Therapeutics and Diagnostics

mRNA has built its reputation as a type of vaccine to fight COVID-19, but its capabilities extend beyond vaccines into therapeutics and even diagnostics.

August 17, 2021
·
4 min read
·
Gail Dutton
Business

Hope in the Wake of Recent Failures in Huntington’s Disease

While treatments exist to manage the symptoms of the disease, nothing has proven to be curative – yet. Several biopharma companies are working hard to change that.

August 17, 2021
·
7 min read
·
Heather McKenzie
Business

Eli Lilly Splits and Delegates Bio-Medicines Unit to Increase Focus

Eli Lilly is undertaking a strategic transformation that will result in the formation of new business units.

August 17, 2021
·
3 min read
·
Alex Keown
FDA

FDA Slams Sesen Bio with CRL for Bladder Cancer Drug Vicineum

The FDA recommended additional clinical and statistical data analyses of Vicineum, as well as issues related to the company’s Chemistry, Manufacturing, and Controls.

August 17, 2021
·
2 min read
·
Alex Keown